Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859195 · ClinicalTrials.gov registry record
Monoclonal Antibody-based Multipurpose Microbicides
A clinical trial, sponsored by The Miriam Hospital.
- Completed
- Registry status
- 36
- Enrollment target
NCT01859195: Completed study, sponsored by The Miriam Hospital.
NCT01859195 is a clinical trial that has completed, run by The Miriam Hospital. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01859195 has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this project is to explore women's thoughts, opinions, and ideas about vaginal products. Women who enroll in the project will complete a brief demographics and sexual behavior questionnaire.
Primary Outcome
Frequency of product use during specified sex in the past 12 months. Response options: 0= None of the time; 1 = Some of the time, 2 = Half of the time, 3 = Most of the time; 4 = All of the time; 5 = Not applicable (did not have specified sex)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-05 |
| Est. Completion | 2026-01 |
What the finished NCT01859195 record still lists
NCT01859195 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01859195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01859195 about?
NCT01859195 is a clinical study titled "Monoclonal Antibody-based Multipurpose Microbicides". The purpose of this project is to explore women's thoughts, opinions, and ideas about vaginal products. Women who enroll in the project will complete a brief demographics and sexual behavior questionnaire.
What is the current status of trial NCT01859195?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2013-05. Estimated completion is 2026-01.
Who is sponsoring clinical trial NCT01859195?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia